Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700024908

Trial Profile

Clinical Trials Insight: 700024908

Phase of Trial: Phase III

Latest Information Update: 21 Jan 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jan 2017 Results (n=1248) of a combined analysis from SPIRITS, TOP-002 and START trials, presented at the 2017 Gastrointestinal Cancers Symposium
    • 18 Jan 2014 Results of a predictive biomarker analysis presented at the 2014 Gastrointestinal Cancers Symposium.
    • 31 May 2009 Results presented at ASCO 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top